Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SB Peptides is a French contract research organization (CRO) and contract manufacturing organization (CMO) specializing in custom peptide synthesis and design. Based in the Biopôle Clermont-Limagne, the company provides high-quality peptides for research and preclinical applications, including complex modifications, long sequences, and cyclic structures. SB Peptides supports the life sciences industry by offering expertise in solid-phase and liquid-phase synthesis, as well as peptide-drug conjugate (PDC) development. Their services cater to pharmaceutical, biotechnology, and academic researchers globally, focusing on rapid delivery and technical support for challenging sequences. The company also offers specialized services such as fluorescent labeling, biotinylation, and the production of stable isotope-labeled peptides. With a focus on difficult-to-synthesize peptides, SB Peptides has established itself as a reliable partner for early-stage drug discovery and development projects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SB Peptides.